This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Betti, C. J. Articles by Vaughan, A. T. M. Search for Related Content PubMed PubMed Citation Articles by Betti, C. J. Articles by Vaughan, A. T. M.

Apoptotic Triggers Initiate Translocations within the MLL Gene Involving the Nonhomologous End Joining Repair System¹

Program in Molecular Biology [C. J. B., M. J. V.], Departments of Radiation Oncology [A. T. M. V.] and Medicine [M. O. D.], Loyola University Medical Center, Maywood, Illinois 60153

Translocations involving the MLL gene at 11q23 are a frequent finding in therapy-related leukemia and are concentrated within a short, 8.3-kb tract of DNA, the breakpoint cluster region. In addition, a specific site adjacent to exon 12 within this region of MLL is cleaved in cells undergoing apoptosis. We show here, using human TK6 lymphoblastoid cells, that irradiation and the apoptotic trigger anti-CD95 antibody are each able to initiate translocations at the MLL exon 12 cleavage site. The translocation junctions produced contain regions of microhomology consistent with operation of the nonhomologous end joining (NHEJ) repair process. Participation of the NHEJ process is supported by the identification of the NHEJ component DNA-PKcs at the site of apoptotic cleavage. Suppression of DNA-PKcs function by the phosphatidylinositol 3-kinase inhibitor wortmannin compromises DNA end joining, increases site-specific cleavage within MLL, and eliminates MLL-restricted translocations. We propose that activation of apoptotic effector nucleases alone is sufficient to generate proleukemogenic translocations and raises the possibility that some of these may persist in cells that evade apoptotic execution and survive.

This article has been cited by other articles:

				S. Britton, P. Frit, D. Biard, B. Salles, and P. Calsou ARTEMIS Nuclease Facilitates Apoptotic Chromatin Cleavage Cancer Res., October 15, 2009; 69(20): 8120 - 8126. [Abstract] [Full Text] [PDF]

				R. K. Slany The molecular biology of mixed lineage leukemia Haematologica, July 1, 2009; 94(7): 984 - 993. [Abstract] [Full Text] [PDF]

				M. S. Brassesco, A. P. Montaldi, D. E. Gras, M. L. Camparoto, N. M. Martinez-Rossi, C. A. Scrideli, L. G. Tone, and E. T. Sakamoto-Hojo Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors Mutagenesis, March 1, 2009; 24(2): 153 - 160. [Abstract] [Full Text] [PDF]

				B. W. Robinson, N.-K. V. Cheung, C. P. Kolaris, S. C. Jhanwar, J. K. Choi, N. Osheroff, and C. A. Felix Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome Blood, April 1, 2008; 111(7): 3802 - 3812. [Abstract] [Full Text] [PDF]

				S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten Dietary flavonoids induce MLL translocations in primary human CD34+ cells Carcinogenesis, August 1, 2007; 28(8): 1703 - 1709. [Abstract] [Full Text] [PDF]

				A. M. Azarova, Y. L. Lyu, C.-P. Lin, Y.-C. Tsai, J. Y.-N. Lau, J. C. Wang, and L. F. Liu From the Cover: Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies PNAS, June 26, 2007; 104(26): 11014 - 11019. [Abstract] [Full Text] [PDF]

				E. S. Hars, Y. L. Lyu, C.-P. Lin, and L. F. Liu Role of Apoptotic Nuclease Caspase-Activated DNase in Etoposide-Induced Treatment-Related Acute Myelogenous Leukemia. Cancer Res., September 15, 2006; 66(18): 8975 - 8979. [Abstract] [Full Text] [PDF]

				R. C. Briggs, K. E. Shults, L. A. Flye, S. A. McClintock-Treep, M. H. Jagasia, S. A. Goodman, F. I. Boulos, J. W. Jacobberger, G. T. Stelzer, and D. R. Head Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in Apoptosis. Cancer Res., May 1, 2006; 66(9): 4645 - 4651. [Abstract] [Full Text] [PDF]

				A. R. Mistry, C. A. Felix, R. J. Whitmarsh, A. Mason, A. Reiter, B. Cassinat, A. Parry, C. Walz, J. L. Wiemels, M. R. Segal, et al. DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia N. Engl. J. Med., April 14, 2005; 352(15): 1529 - 1538. [Abstract] [Full Text] [PDF]

				J. Libura, D. J. Slater, C. A. Felix, and C. Richardson Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion Blood, March 1, 2005; 105(5): 2124 - 2131. [Abstract] [Full Text] [PDF]

				A. Khobta, C. Carlo-Stella, and G. Capranico Specific Histone Patterns and Acetylase/Deacetylase Activity at the Breakpoint-Cluster Region of the Human MLL Gene Cancer Res., April 15, 2004; 64(8): 2656 - 2662. [Abstract] [Full Text] [PDF]

				X. Yu and A. Gabriel Reciprocal Translocations in Saccharomyces cerevisiae Formed by Nonhomologous End Joining Genetics, February 1, 2004; 166(2): 741 - 751. [Abstract] [Full Text] [PDF]

				P. Widlak, J. Lanuszewska, R. B. Cary, and W. T. Garrard Subunit Structures and Stoichiometries of Human DNA Fragmentation Factor Proteins before and after Induction of Apoptosis J. Biol. Chem., July 11, 2003; 278(29): 26915 - 26922. [Abstract] [Full Text] [PDF]

				C. J. Betti, M. J. Villalobos, M. O. Diaz, and A. T. M. Vaughan Apoptotic Stimuli Initiate MLL-AF9 Translocations that Are Transcribed in Cells Capable of Division Cancer Res., March 15, 2003; 63(6): 1377 - 1381. [Abstract] [Full Text] [PDF]